CCL5 serum levels are significantly elevated in patients with HF (92), and by blocking CCL5, inflammation in the cardiac tissue can be targeted to reduce neutrophil and macrophage recruitment (94). The gene discussed is CCL5; the disease is hydrops fetalis.